Efficacy and tolerability of aripiprazole in outpatients with schizophrenia or schizoaffective disorder

被引：0
|
作者：
Shin, D. [1 ]
机构：
[1] Hongseong Med Ctr, Hongseong, South Korea
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2009年 / 19卷
关键词：
D O I：
10.1016/S0924-977X(09)70815-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S515 / S515
页数：1
相关论文
共 50 条
  • [1] A 12-week, naturalistic switch study of the efficacy and tolerability of aripiprazole in stable outpatients with schizophrenia or schizoaffective disorder
    Kim, Chang Yoon
    Chung, Seockhoon
    Lee, Joon-Noh
    Kwon, Jun Soo
    Kim, Do Hoon
    Kim, Chul Eung
    Jeong, Bumseok
    Jeon, Yang-Whan
    Lee, Min-Soo
    Jun, Tae-Youn
    Jung, Hee-Yeon
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2009, 24 (04) : 181 - 188
  • [2] Efficacy, safety, and tolerability of aripiprazole in patients with schizoaffective disorder
    Kujawa, M
    Stringfellow, J
    Hardy, S
    Ali, M
    Iwamoto, T
    Lam, S
    Marcus, R
    Stock, E
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 156 - 156
  • [3] Efficacy and tolerability of aripiprazole depot in schizoaffective disorder: Case report
    Garcia Moreno, M.
    de Cos Milas, A.
    Beatobe Carreno, L.
    Poza Cano, B.
    EUROPEAN PSYCHIATRY, 2018, 48 : S527 - S527
  • [4] Aripiprazole in Schizophrenia and Schizoaffective Disorder: A Review
    Stip, Emmanuel
    Tourjman, Valerie
    CLINICAL THERAPEUTICS, 2010, 32 : S3 - S20
  • [5] Tolerability and efficacy of clozapine combined with lithium in schizophrenia and schizoaffective disorder
    Small, JG
    Klapper, MH
    Malloy, FW
    Steadman, TM
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (03) : 223 - 228
  • [6] Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder
    Kane, JM
    Carson, WH
    Saha, AR
    McQuade, RD
    Ingenito, GG
    Zimbroff, DL
    Ali, MW
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (09) : 763 - 771
  • [7] Efficacy and safety of aripiprazole a 12 weeks, multi-center, open-label switching to aripiprazole study in stable outpatients with schizophrenia or schizoaffective disorder
    Kim, C.
    Chung, S.
    Lee, J.
    Kwon, J.
    Lee, Y.
    Kim, C.
    Oh, K.
    Jeon, Y.
    Ham, B.
    Kim, D.
    Jung, H.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 437 - 437
  • [8] Efficacy and tolerability of aripiprazole in adolescents with schizophrenia
    Nyilas, M.
    Forbes, A.
    Jin, N.
    Ashfaque, S.
    Iwamoto, T.
    Owen, R.
    Carson, W. H.
    Findling, R. L.
    EARLY INTERVENTION IN PSYCHIATRY, 2008, 2 : A99 - A99
  • [9] Efficacy and tolerability of aripiprazole in adolescents with schizophrenia
    Forbes, A.
    Nyilas, M.
    Loze, J.
    Werner, C.
    Johnson, B.
    Owen, R.
    Todorov, S.
    Carson, W. H.
    EUROPEAN PSYCHIATRY, 2008, 23 : S115 - S115
  • [10] Efficacy and tolerability of switching to long-acting injectable (LAI) aripiprazole in outpatients with schizophrenia
    Fernandez-Abascal Puente, B.
    Juncal Ruiz, M.
    Landera Rodriguez, R.
    EUROPEAN PSYCHIATRY, 2016, 33 : S255 - S256
12345